Insulet Corp. (PODD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1156053,
"name": "Insulet Corp.",
"stock_name": "Insulet Corp.",
"full_name": "Insulet Corp.",
"name_url": "stocks-analysis/insulet-corp",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "315.92",
"chg": 6.92,
"chgp": "2.24%",
"dir": 1,
"prev_price": "309.00",
"mcapval": "24,606.41",
"mcap": "Mid Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2325,
"indexname": "S&P 500",
"isin": "US45784P1012",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "1.51 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/insulet-corp-1156053-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Insulet Corp. Experiences Evaluation Revision Amid Strong Market Performance and Technical Indicators",
"link": "https://www.marketsmojo.com/news/stocks-in-action/insulet-corps-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-mixed-signals-3652025",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InsuletCorp_technicaldot_3652025.png",
"date": "2025-10-28 15:22:08",
"description": "Insulet Corp., a midcap in the Pharmaceuticals & Biotechnology sector, has shown strong performance with a 37.10% return over the past year, significantly outperforming the S&P 500. Current stock price is $325.80, reflecting recent market evaluations amid mixed technical indicators and a notable trading range."
},
{
"title": "Is Insulet Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3651453",
"imagepath": "",
"date": "2025-10-28 11:43:39",
"description": "As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands on both weekly and monthly time frames. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating mixed signals. \n\nIn terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P 500's 15.47%, and over the past year, it has returned 35.05% versus the S&P 500's 16.90%. However, over the longer term, it has underperformed the S&P 500 significantly in the 3-year, 5-year, and 10-year periods...."
},
{
"title": "Is Insulet Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3647907",
"imagepath": "",
"date": "2025-10-27 11:54:47",
"description": "As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating some mixed signals. \n\nIn terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P's 15.47%, and over the past year, it has returned 35.05% versus the S&P's 16.90%. However, over the longer three-year and five-year periods, Insulet has significantly underperformed the S&P 500...."
},
{
"title": "Is Insulet Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3646441",
"imagepath": "",
"date": "2025-10-26 11:29:29",
"description": "As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish outlook from Bollinger Bands, KST, and OBV on both weekly and monthly time frames. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating some mixed signals. \n\nIn terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to 15.47%, and over the past year with 35.05% against 16.90%. However, it has lagged significantly over the 3-year, 5-year, and 10-year periods...."
},
{
"title": "Insulet Corp. Experiences Evaluation Revision Amidst Mixed Market Dynamics and Strong Performance",
"link": "https://www.marketsmojo.com/news/stocks-in-action/insulet-corp-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-mixed-indicators-3601042",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InsuletCorp_technicaldot_3601042.png",
"date": "2025-10-07 19:51:51",
"description": "Insulet Corp., a midcap in the Pharmaceuticals & Biotechnology sector, has shown strong performance with a 35.55% return over the past year, outpacing the S&P 500. Despite recent challenges, the company demonstrates resilience and adaptability amid mixed technical indicators and market dynamics."
},
{
"title": "Is Insulet Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3599233",
"imagepath": "",
"date": "2025-10-07 12:21:52",
"description": "As of 3 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals across time frames. The RSI shows no signal on the weekly chart and is bearish on the monthly chart. Bollinger Bands reflect a mildly bearish stance weekly and bullish monthly. Daily moving averages are mildly bullish, suggesting some short-term strength. KST and OBV are both bullish on the monthly, but the weekly KST is bullish with no trend in OBV.\n\nIn terms of performance, Insulet has underperformed the S&P 500 over the past month (-10.54% vs. 4.15%) and the past three years (26.96% vs. 82.57%), but it has outperformed the index year-to-date (19.39% vs. 14.18%) and over the past year (35.55% vs. 17.82%). Overall, the current stance is mildly bullish, driven by monthly bullish indicators despite some bearish s..."
},
{
"title": "Is Insulet Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3593958",
"imagepath": "",
"date": "2025-10-06 12:11:48",
"description": "As of 3 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly MACD and OBV show mildly bearish signals. The monthly indicators, including MACD and KST, are bullish, suggesting some strength in the longer term. However, the RSI on a monthly basis is bearish, indicating potential weakness. \n\nIn terms of performance, Insulet has outperformed the S&P 500 year-to-date with an 18.40% return compared to the S&P's 14.18%, and it has also shown a strong 34.40% return over the past year versus the S&P's 17.82%. However, over the longer three and five-year periods, Insulet has underperformed significantly against the S&P 500...."
},
{
"title": "Is Insulet Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3546622",
"imagepath": "",
"date": "2025-09-20 19:37:09",
"description": "As of 19 August 2025, the technical trend for Insulet Corp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the monthly RSI is bearish, and the KST shows a mixed signal with weekly mildly bearish and monthly bullish readings. The Dow Theory indicates a mildly bearish trend on the weekly but bullish on the monthly. Overall, the indicators suggest a bullish stance, albeit with some caution due to mixed signals in the RSI and KST.\n\nIn terms of performance, Insulet Corp. has outperformed the S&P 500 on a year-to-date basis with a return of 27.75% compared to 12.22%, and over the past year with a return of 41.25% versus 17.14%. However, over the longer term, it has underperformed the S&P 500 in the 3-year, 5-year, and 10-year periods...."
},
{
"title": "Is Insulet Corp. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-overvalued-or-undervalued-3543157",
"imagepath": "",
"date": "2025-09-20 18:12:13",
"description": "As of 7 August 2025, the valuation grade for Insulet Corp. has moved from fair to very expensive, indicating a significant shift in its market perception. The company appears overvalued based on its current valuation ratios, including a P/E ratio of 51, a Price to Book Value of 16.49, and an EV to EBITDA of 51.48. In comparison to peers, Insulet's P/E ratio is notably higher than ResMed, Inc. at 37.73 and Zimmer Biomet Holdings, Inc. at 29.65, which further supports the conclusion of overvaluation.\n\nRecent stock performance shows that while Insulet has outperformed the S&P 500 year-to-date with a return of 27.75% compared to 12.22%, its longer-term returns over three and five years have lagged behind the index, with returns of 30.79% and 48.21% respectively, versus 70.41% and 96.61% for the S&P 500. This trend suggests that despite short-term gains, the company's elevated valuation may not be sustainable in..."
}
],
"total": 14,
"sid": "1156053",
"stock_news_url": "https://www.marketsmojo.com/news/insulet-corp-1156053"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Insulet Corp. Experiences Evaluation Revision Amid Strong Market Performance and Technical Indicators

2025-10-28 15:22:08

Insulet Corp., a midcap in the Pharmaceuticals & Biotechnology sector, has shown strong performance with a 37.10% return over the past year, significantly outperforming the S&P 500. Current stock price is $325.80, reflecting recent market evaluations amid mixed technical indicators and a notable trading range.

Is Insulet Corp. technically bullish or bearish?

2025-10-28 11:43:39

As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands on both weekly and monthly time frames. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating mixed signals. In terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P 500's 15.47%, and over the past year, it has returned 35.05% versus the S&P 500's 16.90%. However, over the longer term, it has underperformed the S&P 500 significantly in the 3-year, 5-year, and 10-year periods....

Is Insulet Corp. technically bullish or bearish?

2025-10-27 11:54:47

As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating some mixed signals. In terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P's 15.47%, and over the past year, it has returned 35.05% versus the S&P's 16.90%. However, over the longer three-year and five-year periods, Insulet has significantly underperformed the S&P 500....

Is Insulet Corp. technically bullish or bearish?

2025-10-26 11:29:29

As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish outlook from Bollinger Bands, KST, and OBV on both weekly and monthly time frames. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating some mixed signals. In terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to 15.47%, and over the past year with 35.05% against 16.90%. However, it has lagged significantly over the 3-year, 5-year, and 10-year periods....

Insulet Corp. Experiences Evaluation Revision Amidst Mixed Market Dynamics and Strong Performance

2025-10-07 19:51:51

Insulet Corp., a midcap in the Pharmaceuticals & Biotechnology sector, has shown strong performance with a 35.55% return over the past year, outpacing the S&P 500. Despite recent challenges, the company demonstrates resilience and adaptability amid mixed technical indicators and market dynamics.

Is Insulet Corp. technically bullish or bearish?

2025-10-07 12:21:52

As of 3 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals across time frames. The RSI shows no signal on the weekly chart and is bearish on the monthly chart. Bollinger Bands reflect a mildly bearish stance weekly and bullish monthly. Daily moving averages are mildly bullish, suggesting some short-term strength. KST and OBV are both bullish on the monthly, but the weekly KST is bullish with no trend in OBV. In terms of performance, Insulet has underperformed the S&P 500 over the past month (-10.54% vs. 4.15%) and the past three years (26.96% vs. 82.57%), but it has outperformed the index year-to-date (19.39% vs. 14.18%) and over the past year (35.55% vs. 17.82%). Overall, the current stance is mildly bullish, driven by monthly bullish indicators despite some bearish s...

Is Insulet Corp. technically bullish or bearish?

2025-10-06 12:11:48

As of 3 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly MACD and OBV show mildly bearish signals. The monthly indicators, including MACD and KST, are bullish, suggesting some strength in the longer term. However, the RSI on a monthly basis is bearish, indicating potential weakness. In terms of performance, Insulet has outperformed the S&P 500 year-to-date with an 18.40% return compared to the S&P's 14.18%, and it has also shown a strong 34.40% return over the past year versus the S&P's 17.82%. However, over the longer three and five-year periods, Insulet has underperformed significantly against the S&P 500....

Is Insulet Corp. technically bullish or bearish?

2025-09-20 19:37:09

As of 19 August 2025, the technical trend for Insulet Corp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the monthly RSI is bearish, and the KST shows a mixed signal with weekly mildly bearish and monthly bullish readings. The Dow Theory indicates a mildly bearish trend on the weekly but bullish on the monthly. Overall, the indicators suggest a bullish stance, albeit with some caution due to mixed signals in the RSI and KST. In terms of performance, Insulet Corp. has outperformed the S&P 500 on a year-to-date basis with a return of 27.75% compared to 12.22%, and over the past year with a return of 41.25% versus 17.14%. However, over the longer term, it has underperformed the S&P 500 in the 3-year, 5-year, and 10-year periods....

Is Insulet Corp. overvalued or undervalued?

2025-09-20 18:12:13

As of 7 August 2025, the valuation grade for Insulet Corp. has moved from fair to very expensive, indicating a significant shift in its market perception. The company appears overvalued based on its current valuation ratios, including a P/E ratio of 51, a Price to Book Value of 16.49, and an EV to EBITDA of 51.48. In comparison to peers, Insulet's P/E ratio is notably higher than ResMed, Inc. at 37.73 and Zimmer Biomet Holdings, Inc. at 29.65, which further supports the conclusion of overvaluation. Recent stock performance shows that while Insulet has outperformed the S&P 500 year-to-date with a return of 27.75% compared to 12.22%, its longer-term returns over three and five years have lagged behind the index, with returns of 30.79% and 48.21% respectively, versus 70.41% and 96.61% for the S&P 500. This trend suggests that despite short-term gains, the company's elevated valuation may not be sustainable in...

View All News